Significados de molecular disease en inglés

Interestingly, the latest advances in AMD research also highlight common molecular disease pathways with other neurodegenerative disorders.

Thus, there is a high clinical need for molecular disease biomarkers to aid in differentiating these distinct phenotypes.

These cells remain after IM therapy, even when apparently complete responses are achieved, and they probably explain molecular disease persistence.

These patients are typically younger and suffer from conditions caused by a known molecular disease mechanism and a peculiar sarcopenic phenotype.

Fluorogenic probes that signal the presence of specific DNA or RNA sequences are key enabling tools for molecular disease diagnosis and imaging studies.

Here, we performed whole exome sequencing in 79 consanguineous or familial cases of suspected nephronophthisis in order to determine the underlying molecular disease cause.

Molecular disease mechanisms downstream of functional SMN loss are still largely unknown.